Stock listing

Lang & Schwarz:A2GS5D Dermapharm Holding SE Aktie

German listing (Lang & Schwarz) of Dermapharm Holding SE · home listing Xetra:DMP

Follow Dermapharm Holding SE into a list and get an email when it puts out news.

Home listing price · XETR:DMP

€32.75 EUR -1.30 (-3.8%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, XETR:DMP

Past year -7.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€32.75 – €33.45 EURNov 20, 2026
Volume
42,627 sharesNov 20, 2026
Market cap
€1.62B EURAt the close on Nov 20, 2026 · price × 49.54M shares outstanding
52-week range
€32.75 – €51.90 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€1.26M EURMedian day 22,921 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Dermapharm Holding SE logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Xetra:DMP · Home€32.75 EUR-1.30 (-3.8%)42,627€32.95€33.45€32.75€34.05Close on Nov 20, 2026
OTC:DMPHF$38.84 USD-8.85 (-18.6%)200$38.84$38.84$38.84$47.69Close on Nov 13, 2026
Dusseldorf:DMP€32.80 EUR-0.50 (-1.5%)—€32.55€33.15€32.55€33.30Close on Nov 20, 2026
Hamburg:DMP€33.30 EUR-0.60 (-1.8%)120€32.55€33.30€32.55€33.90Close on Nov 20, 2026
Munich:DMP€32.95 EUR-1.40 (-4.1%)—€32.95€32.95€32.95€34.35Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · XETR:DMP · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€32.75-1.30-3.8%€32.95€33.45€32.7542,627
€34.05-0.95-2.7%€35.35€35.35€33.9034,739
€35.00-0.45-1.3%€35.25€35.45€34.7532,375
€35.45+0.20+0.6%€35.20€35.70€34.8026,549
€35.25+0.30+0.9%€35.35€35.85€34.8549,688
€34.95-3.65-9.5%€37.90€38.70€34.95116,463
€38.60+0.10+0.3%€38.90€39.20€38.5021,340
€38.50+0.15+0.4%€38.60€38.60€37.9528,426
€38.35+0.35+0.9%€38.20€38.55€37.9013,366
€38.00-0.50-1.3%€38.10€38.55€37.4523,591
€38.50-0.40-1.0%€39.00€39.35€38.2513,229
€38.90+0.45+1.2%€38.55€39.05€38.308,350
€38.45-0.65-1.7%€38.85€39.05€38.3513,592
€39.10+0.55+1.4%€38.50€39.15€38.508,213
€38.550.000.0%€38.50€38.70€38.405,424
€38.55+0.35+0.9%€38.20€38.55€38.1517,671
€38.20-0.20-0.5%€38.25€38.70€38.1015,757
€38.40+0.55+1.5%€38.70€38.70€37.8011,217
€37.85-0.55-1.4%€38.50€38.95€37.8511,031
€38.40-0.30-0.8%€38.70€38.75€38.2018,424
€38.70-0.10-0.3%€38.60€38.90€38.459,838
€38.80+0.55+1.4%€38.00€39.05€38.0014,649
€38.25+0.35+0.9%€37.40€38.35€37.4011,373
€37.90+0.05+0.1%€37.55€38.25€37.5534,732
€37.85-0.30-0.8%€38.70€38.70€37.6514,600
€38.15-0.40-1.0%€38.35€38.85€38.1527,513
€38.55+0.70+1.8%€38.00€38.85€37.8515,973
€37.85-0.45-1.2%€38.30€38.50€37.8510,213
€38.30-0.10-0.3%€38.75€38.75€38.0512,585
€38.40+0.25+0.7%€38.15€38.90€38.1511,821
€38.15-0.75-1.9%€38.65€38.75€38.0018,235
€38.90+0.80+2.1%€37.75€39.10€37.7530,849
€38.10+0.65+1.7%€37.35€38.35€37.3543,542
€37.45-0.05-0.1%€37.40€38.05€37.3517,100
€37.50-0.95-2.5%€38.40€38.40€37.4023,954
€38.45-0.75-1.9%€38.90€38.95€38.2514,727
€39.20+0.15+0.4%€39.00€39.70€39.0014,969
€39.05-0.30-0.8%€39.35€39.60€39.0512,557
€39.35+0.30+0.8%€39.05€39.50€39.0514,498
€39.05-0.25-0.6%€39.10€39.40€38.9515,019
€39.30+0.05+0.1%€39.05€39.60€39.0022,250
€39.25-0.50-1.3%€39.85€39.85€39.2018,478
€39.75+0.95+2.4%€38.70€39.95€38.7028,469
€38.80-0.10-0.3%€39.20€39.20€38.6026,550
€38.90-0.10-0.3%€39.25€39.85€38.9085,291
€39.00+0.45+1.2%€38.30€39.15€38.3014,413
€38.55+0.75+2.0%€38.45€38.85€38.0020,577
€37.80-0.10-0.3%€38.00€38.00€37.4550,921
€37.90+0.50+1.3%€37.25€38.05€37.2544,305
€37.40-0.90-2.3%€38.30€38.30€37.3543,615
€38.30-0.50-1.3%€38.55€38.70€38.2029,073
€38.80-0.15-0.4%€38.15€39.20€38.1528,704
€38.95+0.40+1.0%€38.70€39.10€38.3531,315
€38.55-1.05-2.7%€39.55€39.55€38.2034,423
€39.60+0.65+1.7%€38.50€39.60€38.5028,800
€38.95+0.65+1.7%€38.30€39.35€38.3040,395
€38.30-0.70-1.8%€38.80€38.85€38.3038,152
€39.000.000.0%€40.15€40.15€38.9511,839
€39.00-0.55-1.4%€39.50€39.50€39.00476,211
€39.55-0.55-1.4%€39.95€40.30€39.4028,808
€40.10+0.05+0.1%€39.45€40.40€38.7028,586
€40.05-1.95-4.6%€41.00€41.55€40.0536,571
€42.00+2.20+5.5%€40.20€42.15€39.4555,530
€39.80-0.35-0.9%€39.95€40.15€39.6022,063
€40.15+0.25+0.6%€39.90€40.15€39.3024,191
€39.90-0.40-1.0%€40.80€40.80€39.6525,977
Ticker
Lang & Schwarz:A2GS5D
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Latest news

All Dermapharm Holding SE news

Dermapharm Holding SE on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
8 in the last 12 months · 10 in all · newest Aug 25, 2026 · oldest 2025
Calls
1 call with a replay · 1 with a transcript · latest Aug 25, 2026
Decks
51 decks · latest Nov 12, 2026

Where Dermapharm Holding SE is listed

ListingExchangeCountryCurrency
Xetra:DMP · Home listingXetraGermanyEUR
Tradegate:DMPTradegateGermanyEUR
gettex:DMPgettexGermanyEUR
Stuttgart:DMPStuttgartGermanyEUR
LS Exchange:A2GS5DLS ExchangeGermanyEUR
LSIN:0A5JLSINUnited KingdomEUR
OTC:DMPHFOTCUnited StatesUSD
Frankfurt:DMPFrankfurtGermanyEUR
Hanover:DMPHanoverGermanyEUR
Lang & Schwarz:A2GS5D · This pageLang & SchwarzGermanyEUR
BX Swiss:DMPBX SwissSwitzerlandCHF
Dusseldorf:DMPDusseldorfGermanyEUR
Hamburg:DMPHamburgGermanyEUR
Munich:DMPMunichGermanyEUR
Aquis:DMPDAquisUnited KingdomEUR
VIE:DMPViennaAustriaEUR
Aquis:DMPDAquisUnited KingdomEUR
Turquoise:DMPDTurquoiseUnited KingdomEUR

Valuation

P/E 12.4× against a median of 19.1×: 3rd lowest of 10 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
€2.62B EUR
P/E
12.4×
EV/sales
2.2×
EV/EBITDA
6.9×
Price/book
2.9×
Gross margin
33.8%
Operating margin
20.9%
Net margin
11.1%
Debt to equity
2.0×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Dermapharm Holding SE · XETR:DMPUS$1.78BUS$2.88B12.4×2.2×6.9×2.9×11.1%2.0×n/a
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A · SSE:603707US$1.90BUS$1.52B29.8×2.5×n/a1.8×10.4%0.0×n/a
Shenzhen Kangtai Biological Products Co. Ltd. Class A · SZSE:300601US$1.80BUS$1.74B103×4.7×n/a1.2×4.8%0.2×n/a
Shilpa Medicare Limited · NSE:SHILPAMEDUS$1.79BUS$1.85B50.0×9.3×33.5×6.0×18.1%0.2×n/a
Shenyang Xingqi Pharmaceutical Co., Ltd. Class A · SZSE:300573US$1.76BUS$1.69B14.6×4.0×n/a5.2×28.6%0.0×n/a
Eton Pharmaceuticals, Inc. · NASDAQ:ETONUS$1.76BUS$1.71B35.2×12.1×38.7×20.2×35.4%0.1×0.57
United Laboratories International Holdings Ltd. · HKEX:3933US$1.73BUS$863.1M5.5×0.4×2.0×0.7×15.8%0.3×n/a
H. Lundbeck A/S Class A · OMXCOP:HLUN_AUS$1.71BUS$2.45B2.9×0.6×1.7×0.4×15.5%0.3×n/a
Harbin Pharmaceutical Group Co., Ltd. Class A · SSE:600664US$1.70BUS$1.22B17.9×0.5×n/a1.8×3.9%0.0×n/a
Mayinglong Pharmaceutical Group Co., Ltd. Class A · SSE:600993US$1.70BUS$1.34B19.1×2.2×n/a2.5×14.9%0.0×n/a
Ultragenyx Pharmaceutical Inc. · NASDAQ:RAREUS$1.68BUS$2.60Bn/a3.6×n/an/a−71.8%n/a1.35
Median of the othersUS$1.74BUS$1.70B19.1×3.0×17.7×1.8×15.2%0.1×0.96

Forecasts

Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
51.00 EUR · Analysts' mean
EPS, year to Dec 2026
2.53 · 1 analyst
Revenue, year to Dec 2026
1.19B · 3 analysts

Team and board

OfficerRole
Britta HambergerInvestor Relations & Corporate Communications
Dermapharm Holding SEir.dermapharm.de

Events

Calls

CallWhenStatus
Dermapharm Holding (Xetra:DMP) Q2 2026 Earnings CallTue, Aug 25, 2026 · 8:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 12, 2026 · After close+0.9%
Q2 2026Aug 25, 2026 · After close−4.6%
Q1 2026May 13, 2026 · After close+7.7%
Q4 2025Mar 30, 2026 · After close−3.6%
Q3 2025Nov 13, 2025 · After close+2.2%
Q2 2025Aug 26, 2025 · After close+1.2%
Q1 2025May 15, 2025 · Before open−8.7%
Q4 2024Mar 14, 2025+11.3%
Q3 2024Nov 14, 2024 · Before open+8.6%
Q2 2024Aug 27, 2024 · Before open−2.0%
All 20 quarters
QuarterResultsShare move
Q1 2024May 15, 2024 · Before open+3.3%
Q4 2023Mar 28, 2024 · Before open−4.5%
Q3 2023Nov 15, 2023 · Before open+0.6%
Q2 2023Aug 16, 2023 · Before open+12.8%
Q1 2023May 15, 2023 · Before open+8.0%
Q4 2022Mar 28, 2023 · Before open+0.6%
Q3 2022Nov 16, 2022 · Before open+2.5%
Q2 2022Sep 7, 2022 · Before open−3.3%
Q1 2022May 18, 2022 · Before open−13.4%
Quarter to Sep 30, 2021Nov 16, 2021−6.1%

Open Events

Decks

DeckKindSlidesDate
Dermapharm Hldg — Q3 2026 Earnings PresentationEarnings24 slidesNov 12, 2026
Q1 2026 Earnings PresentationEarnings21 slidesMay 13, 2026
FY2025 Earnings PresentationEarnings24 slidesMar 31, 2026
Fact Sheet (2026)Fact sheet2 slidesMar 30, 2026
Fact Sheet (December 2025)Fact sheet2 slidesDec 31, 2025
Q3 2025 Earnings PresentationEarnings23 slidesNov 13, 2025
H1 2025 Earnings PresentationEarnings23 slidesAug 26, 2025
Fact Sheet (June 2025)Fact sheet2 slidesJun 30, 2025
Shareholder Meeting (June 2025)Shareholder meeting15 slidesJun 26, 2025
Q1 2025 Earnings PresentationEarnings22 slidesMay 15, 2025
Show 50 decks
DeckKindSlidesDate
FY2024 Earnings PresentationEarnings24 slidesMar 28, 2025
Q3 2024 Earnings PresentationEarnings23 slidesNov 14, 2024
Fact Sheet (November 2024)Fact sheet2 slidesNovember 2024
H1 2024 Earnings PresentationEarnings22 slidesAug 27, 2024
Fact Sheet (June 2024)Fact sheet2 slidesJun 30, 2024
Q1 2024 Earnings PresentationEarnings20 slidesMay 15, 2024
Fact Sheet (March 2024)Fact sheet2 slidesMarch 2024
Fact Sheet (March 2024)Fact sheet2 slidesMarch 2024
Fact Sheet (March 2024)Fact sheet2 slidesMarch 2024
Q3 2023 Earnings PresentationEarnings21 slidesNov 15, 2023
Q3 2023 Earnings PresentationEarnings17 slidesNov 15, 2023
H1 2023 Earnings PresentationEarnings28 slidesAug 29, 2023
Q1 2023 Earnings PresentationEarnings19 slidesMay 15, 2023
Q1 2023 Earnings PresentationEarnings16 slidesMay 15, 2023
Investor Day (November 2022)Investor day48 slidesNov 22, 2022
H1 2022 Earnings PresentationEarnings18 slidesSep 7, 2022
Q1 2022 Earnings PresentationEarnings18 slidesMay 18, 2022
Q1 2022 Earnings PresentationEarnings14 slidesMay 18, 2022
FY2021 Earnings PresentationEarnings21 slidesApr 12, 2022
Investor Day (2022)Investor day29 slides2022
Investor Day (2022)Investor day15 slides2022
Investor Day (2022)Investor day35 slides2022
Q3 2021 Earnings PresentationEarnings17 slidesNov 16, 2021
H1 2021 Earnings PresentationEarnings17 slidesSep 7, 2021
Shareholder Meeting (June 2021)Shareholder meeting27 slidesJun 23, 2021
Q1 2021 Earnings PresentationEarnings17 slidesMay 18, 2021
FY2020 Earnings PresentationEarnings22 slidesApr 13, 2021
Q3 2020 Earnings PresentationEarnings17 slidesNov 16, 2020
H1 2020 Earnings PresentationEarnings17 slidesSep 9, 2020
Shareholder Meeting (June 2020)Shareholder meeting20 slidesJun 17, 2020
Q1 2020 Earnings PresentationEarnings17 slidesMay 19, 2020
FY2019 Earnings PresentationEarnings22 slidesApr 8, 2020
Q3 2019 Earnings PresentationEarnings14 slidesNov 20, 2019
H1 2019 Earnings PresentationEarnings16 slidesSep 12, 2019
Shareholder Meeting (June 2019)Shareholder meeting25 slidesJun 4, 2019
Q1 2019 Earnings PresentationEarnings16 slidesMay 21, 2019
FY2018 Earnings PresentationEarnings22 slidesApr 17, 2019
Q3 2018 Earnings PresentationEarnings23 slidesNov 20, 2018
H1 2018 Earnings PresentationEarnings22 slidesSep 12, 2018
Shareholder Meeting (June 2018)Shareholder meeting34 slidesJun 26, 2018

This page holds 50 of 51 decks. Open Decks

Open Decks

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.16B1.18B1.14B1.02B942.9M793.8M700.9M572.4M467.1M444.5M
Cost of revenue773.3M413.7M416.2M363.9M322.2M330.3M317.2M272.7M245.6M243.4M
Gross profit391.7M767.1M719.2M660.8M620.7M463.5M383.7M299.8M221.5M201.0M
Research and development11.2M11.5M10.6M13.2M14.2M12.7M11.2M6.96M6.64M4.82M
Selling, general and administrative13.2M13.6M20.2M16.1M13.1M14.7M12.7M9.83M6.93M3.25M
Operating income221.7M216.9M182.9M243.7M298.5M136.9M119.5M107.5M92.1M86.8M
Depreciation and amortization92.6M86.8M104.6M94.9M55.2M47.4M47.9M24.1M16.2M14.1M
EBITDA314.3M303.7M287.5M338.6M353.6M184.3M167.4M131.6M108.3M100.9M
Interest expense52.7M58.4M59.5M13.9M9.85M10.6M10.9M7.57M7.55M9.69M
Income before tax183.5M172.0M106.0M216.3M293.0M125.3M110.1M104.2M88.0M82.9M
Income tax52.2M60.3M45.5M83.7M84.1M39.4M32.3M29.0M10.3M5.87M
Net income132.4M113.8M62.4M134.2M209.6M85.8M77.2M75.3M77.7M16.8M
Earnings per share, basic2.462.111.162.493.891.591.431.411.440.31

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents203.4M121.2M158.7M149.9M160.3M120.6M115.0M212.8M6.29M3.82M
Short-term investments735.0K511.0K818.0K11.4M11.7M1.04M1.06M1.10M400.0K30.0K
Receivables121.4M105.0M95.4M100.1M76.1M55.5M53.0M34.1M102.6M66.2M
Inventory328.7M339.9M320.8M251.8M240.5M203.3M172.2M115.6M81.1M84.6M
Current assets702.9M593.5M630.5M533.9M519.2M400.1M352.9M371.2M192.9M157.0M
Property, plant and equipment318.5M315.0M330.8M225.7M222.3M199.6M132.6M80.9M56.0M53.4M
Goodwill587.1M576.4M578.5M271.3M264.7M266.3M202.2M54.6M24.6M17.0M
Total assets2.20B2.08B2.16B1.41B1.41B1.22B1.04B704.6M415.3M311.7M
Accounts payable96.3M94.8M86.6M56.1M52.1M50.4M35.4M28.2M23.4M24.5M
Current liabilities342.9M326.9M394.5M217.8M155.6M132.9M102.4M146.4M80.6M115.4M
Long-term debt904.1M877.3M950.7M501.8M565.7M570.5M533.6M232.6M222.3M96.8M
Total debt1.05B979.6M1.08B516.4M580.3M606.8M554.6M304.3M254.7M162.8M
Total liabilities1.50B1.47B1.62B880.3M907.1M899.8M760.4M448.5M341.6M250.9M
Shareholders' equity694.4M604.4M539.2M531.6M497.3M322.0M278.6M252.4M73.7M56.9M
Shares outstanding53.8M53.8M53.8M53.8M53.8M53.8M53.8M53.4M53.8M53.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations181.5M201.4M219.4M288.5M250.4M131.1M100.6M159.1M86.7M76.8M
Capital spending-42.1M-38.2M-41.5M-39.0M-61.2M-40.8M-46.4M-26.0M-74.7M-17.8M
Free cash flow139.4M163.1M177.9M249.5M189.2M90.3M54.2M133.2M12.0M59.0M
Cash from investing-110.0M-29.6M-415.4M-99.0M-129.3M-105.9M-382.2M-110.0M-84.9M-12.3M
Cash from financing13.3M-209.2M204.5M-199.8M-81.0M-14.1M184.0M164.4M-7.98M-55.9M
Dividends paid-48.5M-47.4M-56.5M-116.8M-47.4M-43.1M-41.5M-41.5M-41.5M-41.5M
Share buybacks0107.5M120.0K120.0K
Change in cash82.1M-37.4M7.70M-10.4M41.1M11.3M-97.4M213.6M-6.15M8.59M

Open Financials

Cap table

Built by 6ix from Dermapharm Holding SE’s releases

Common shares
49,540,810
Fully diluted
49,540,810

Fully diluted

LineShares
Common shares49,540,810

Share count over time

CountShares
Nov 22, 202649,540,810

Open Cap table

Shareholders

Register

HolderOf the companyAs of
Beier, Wilhelm77.1%Jul 1, 2025

Funds

HolderSharesValueChangeAs of
Vanguard Total International Stock Index Fund163KUS$7.73M−45,781Jul 31, 2026
iShares Core MSCI EAFE ETF131KUS$6.18M+1,535Jul 31, 2026
Grandeur Peak International Stalwarts Fund127KUS$6.02M−44,316Jul 31, 2026
Vanguard Developed Markets Index Fund106KUS$5.69M−28,016Jun 30, 2026
Grandeur Peak Global Opportunities Fund70,866US$3.35M−3,200Jul 31, 2026
Grandeur Peak Global Contrarian Fund50,562US$2.39M−2,615Jul 31, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund41,706US$1.97M−11,100Jul 31, 2026
iShares MSCI EAFE Small-Cap ETF40,764US$1.93M−12,217Jul 31, 2026
WisdomTree International SmallCap Dividend Fund32,234US$1.74M+396Jun 30, 2026
Schwab International Small-Cap Equity ETF29,183US$1.66M−840May 31, 2026
Show 50 holders
HolderSharesValueChangeAs of
Vanguard European Stock Index Fund25,548US$1.21M−8,335Jul 31, 2026
iShares Core MSCI International Developed Markets ETF23,207US$1.1M+1,821Jul 31, 2026
Grandeur Peak International Opportunities Fund15,198US$719K−2,366Jul 31, 2026
WisdomTree Europe SmallCap Dividend Fund14,335US$773K+300Jun 30, 2026
WisdomTree Dynamic International SmallCap Equity Fund13,676US$737K−242Jun 30, 2026
The Continental Small Company Series10,397US$492K+5,342Jul 31, 2026
Vanguard Total World Stock Index Fund10,219US$483KNo changeJul 31, 2026
International Core Equity 2 Portfolio10,180US$481K+4,861Jul 31, 2026
Grandeur Peak Global Reach Fund8,294US$392K+1,579Jul 31, 2026
College Retirement Equities Fund - Total Global Stock Account7,452US$401K−4,419Jun 30, 2026
Fidelity Total International Index Fund7,127US$337K−2,969Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF5,374US$254K+4,108Jul 31, 2026
Dimensional International Small Cap ETF5,275US$249K+1,631Jul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio4,358US$235KNo changeJun 30, 2026
Dimensional International Core Equity 2 ETF4,275US$202K+1,347Jul 31, 2026
Dimensional International Core Equity Market ETF3,119US$147K+2,097Jul 31, 2026
Avantis International Equity ETF3,073US$175KNo changeMay 31, 2026
WisdomTree Dynamic International Equity Fund3,007US$162K+200Jun 30, 2026
Fidelity SAI International Small Cap Index Fund2,713US$128K−1,062Jul 31, 2026
Vanguard ESG International Stock ETF2,689US$153KNo changeMay 31, 2026
International Vector Equity Portfolio1,992US$94,194+279Jul 31, 2026
Dimensional VA International Small Portfolio1,463US$69,198+1,202Jul 31, 2026
World ex U.S. Targeted Value Portfolio1,235US$58,423+1,111Jul 31, 2026
iShares MSCI World Small-Cap ETF1,149US$65,334−351May 31, 2026
International Small Cap Growth Portfolio1,098US$51,944+295Jul 31, 2026
Parametric International Equity Fund1,095US$51,785No changeJul 31, 2026
Voya Multi-Manager International Small Cap Fund1,053US$49,799NewJul 31, 2026
iShares MSCI Europe Small-Cap ETF1,050US$49,657−525Jul 31, 2026
World ex U.S. Core Equity Portfolio790US$37,369+228Jul 31, 2026
Dimensional World ex U.S. Sustainability Targeted Value Portfolio745US$35,233NewJul 31, 2026
Brighthouse/Dimensional International Small Company Portfolio674US$36,313NewJun 30, 2026
State Street(R) SPDR(R) Portfolio Europe ETF486US$26,199−319Jun 30, 2026
Avantis Responsible International Equity ETF469US$26,703No changeMay 31, 2026
Hotchkis & Wiley International Small Cap Diversified Value Fund400US$21,529No changeJun 30, 2026
Avantis International Small Cap Equity ETF333US$18,960+45May 31, 2026
International Small Company Trust319US$17,169−530Jun 30, 2026
Dimensional International Vector Equity ETF244US$11,510+193Jul 31, 2026
LVIP Dimensional International Core Equity Fund146US$7,858NewJun 30, 2026
Dimensional International Sustainability Core 1 ETF83US$3,915No changeJul 31, 2026
AZL DFA International Core Equity Fund50US$2,694NewJun 30, 2026

This page holds 50 of 52 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Britta HambergerInvestor Relations & Corporate Communications · Since at least Aug 25, 2026
Dermapharm Holding SEir.dermapharm.de · Since at least Aug 25, 2026

Open People

Log in to ask 6ix AI your own questions about Dermapharm Holding SE.